| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/1089253206294400 Inhaled Milrinone: A New Alternative in Cardiac Surgery?Department of Cardiac Anesthesiology, Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada, denault{at}videotron.ca
Cardiac Surgery, Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada
Medicine (Division of Cardiology), Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada
Biostatistics, Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada
Medicine (Division of Cardiology), Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada
Cardiac Surgery, Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada The administration of milrinone through inhalation has been studied in only a few animal and human studies. Compared to the intravenous administration, inhaled milrinone has been shown to reduce pulmonary artery pressure without systemic hypotension. Therefore, this approach could represent an alternative to nitric oxide. This current state of knowledge of intravenous and inhaled milrinone is presented and summarized.
Key Words: milrinone pulmonary artery pressure nitric oxide heart failure
This article has been cited by other articles:
|
||||||||||||||||||||||||

